The ESCMID Fungal Infection Study Group (EFISG) is dedicated to fostering a strong network and promoting knowledge sharing through engaging educational activities, insightful conferences, and impactful publications. Our goal is to boost global awareness and management of fungal diseases (FDs) among everyone, from healthcare professionals and researchers to the general public. FDs are a growing threat to public health, driven by a shifting epidemiology, increasing resistance, and limited available treatments. It's within this context that the EFISG steps up as a key global player. We have been at the forefront, advising the World Health Organization (WHO) on prioritising fungal pathogens, and supporting efforts to enhance diagnostics, develop better antifungal treatments, and strengthen resistance surveillance, all in collaboration with international mycology societies.
Together, we are committed to:
A conceptual framework for nomenclatural stability and validity of medically important fungi: a proposed global consensus guideline for fungal name changes supported by ABP, ASM, CLSI,ECMM, ESCMID-EFISG, EUCAST-AFST, FDLC, IDSA, ISHAM, MMSA, and MSGERC
de Hoog S, Walsh TJ, Ahmed SA, Alastruey-Izquierdo A, Alexander BD, Arendrup MC, Babady E, Bai F-Y,Balada-Llasat J-M, Borman A, Chowdhary A, Clark A, Colgrove RC, Cornely OA, Dingle TC, Dufresne PJ, Fuller J, Gangneux J-P, Gibas C, Glasgow H, Gräser Y,Guillot J, Groll AH, Haase G, Hanson K, Harrington A, Hawksworth DL, Hayden RT, Hoenigl M, Hubka V,Johnson K, Kus JV, Li R, Meis JF, Lackner M, Lanternier F, Leal SM Jr, Lee F, Lockhart SR, Luethy P, Martin I,Kwon- Chung KJ, Meyer W, Nguyen MH, Ostrosky-Zeichner L, Palavecino E, Pancholi P, Pappas PG, ProcopGW, Redhead SA, Rhoads DD, Riedel S, Stevens B, Sullivan KO, Vergidis P, Roilides E, Seyedmousavi A, Tao L,Vicente VA, Vitale RG, Wang Q-M, Wengenack NL, Westblade L, Wiederhold N, White L, Wojewoda CM, Zhang SX. Guidelines or Consensus Documents. J Clin Microbiol. 2023;61(11):e0087323.
Pneumocystis jirovecii pneumonia in intensive care units: a multicenter study by ESGCIP and EFISG
Daniele Roberto Giacobbe, Silvia Dettori, Vincenzo Di Pilato, Erika Asperges, Lorenzo Ball, Enora Berti,Ola Blennow, Bianca Bruzzone, Laure Calvet, Federico Capra, Marzani, Antonio Casabella, Sofia Choudaly, Anais Dartevel, Gennaro De Pascale, Gabriele Di Meco,Melissa Fallon, Louis-Marie Galerneau, Miguel Gallego, Mauro Giacomini, Adolfo González Sáez, LuiseHänsel, Giancarlo Icardi, Koehler P, Katrien Lagrou, Tobias Lahmer, P. Lewis White, Laura Magnasco,Anna Marchese, Cristina Marelli, Mercedes Marín-Arriaza, Ignacio Martin-Loeches, Armand Mekontso-Dessap, Malgorzata Mikulska, Wauters J, Pelosi P, Timsit JF, Bassetti M; JIR-ICU investigators(collaborators); Critically Ill Patients Study Group of the European Society of Clinical Microbiology andInfectious Diseases (ESGCIP), and the Fungal Infection Study Group of the European Society of Clinical Microbiology and Infectious Diseases (EFISG).Crit Care. 2023;27(1):323.
The fungal exposome and health issues
Technical workshop
22-23 June 2023, Rennes, France
If you have questions or comments for our study group, we warmly invite you to contact us!
